IL-31 monoclonal antibodies and methods of use
    1.
    发明授权
    IL-31 monoclonal antibodies and methods of use 有权
    IL-31单克隆抗体和使用方法

    公开(公告)号:EP2301969B1

    公开(公告)日:2015-12-23

    申请号:EP10179383.4

    申请日:2006-05-08

    摘要: There is provided a monoclonal antibody wherein the monoclonal antibody is produced by the hybridoma deposited with the American Type Culture Collection having the ATCC Patent Deposit Designation selected from a first group consisting of: a) ATCC Patent Deposit Designation PTA-6815; b) ATCC Patent Deposit Designation PTA-6816; c) ATCC Patent Deposit Designation PTA-6871; d) ATCC Patent Deposit Designation PTA-6829; and e) ATCC Patent Deposit Designation PTA-6830; or wherein the monoclonal antibody is selected from a second group consisting of: a) ATCC Patent Deposit Designation PTA-6831; b) ATCC Patent Deposit Designation PTA-6872; c) ATCC Patent Deposit Designation PTA-6875; and d) ATCC Patent Deposit Designation PTA-6873; for use in treating a disease selected from the group consisting of prurigo nodularis; cutaneous T cell lymphoma; atopic dermatitis; contact dermatitis; drug-induced allergic reactions; skin-tropic viruses; viral associated pruritis; vitiligo; alopecia aerata; acne rosacea; acne vulgaris; and bullous pemphigoid.

    摘要翻译: 提供单克隆抗体,其中单克隆抗体由保藏有美国典型培养物保藏中心的杂交瘤产生,所述杂交瘤具有选自以下的第一组的ATCC专利保藏名称:a)ATCC专利保藏名称PTA-6815; b)ATCC专利保藏号PTA-6816; c)ATCC专利保藏号PTA-6871; d)ATCC专利保藏号PTA-6829; 和e)ATCC专利保藏号PTA-6830; 或其中所述单克隆抗体选自由以下组成的第二组:a)ATCC专利保藏名称PTA-6831; b)ATCC专利保藏号PTA-6872; c)ATCC专利保藏名称PTA-6875; 和d)ATCC专利保藏号PTA-6873; 用于治疗选自结节性痒疹的疾病; 皮肤T细胞淋巴瘤; 特应性皮炎; 接触性皮炎; 药物引起的过敏反应; 皮肤热带病毒; 病毒性相关性瘙痒症 白癜风; 秃头症 痤疮性红斑痤疮 寻常痤疮 和大疱性类天疱疮。